These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

480 related articles for article (PubMed ID: 27252617)

  • 1. Multi-Target Directed Donepezil-Like Ligands for Alzheimer's Disease.
    Unzeta M; Esteban G; Bolea I; Fogel WA; Ramsay RR; Youdim MB; Tipton KF; Marco-Contelles J
    Front Neurosci; 2016; 10():205. PubMed ID: 27252617
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ASS234, As a New Multi-Target Directed Propargylamine for Alzheimer's Disease Therapy.
    Marco-Contelles J; Unzeta M; Bolea I; Esteban G; Ramsay RR; Romero A; Martínez-Murillo R; Carreiras MC; Ismaili L
    Front Neurosci; 2016; 10():294. PubMed ID: 27445665
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Donepezil + propargylamine + 8-hydroxyquinoline hybrids as new multifunctional metal-chelators, ChE and MAO inhibitors for the potential treatment of Alzheimer's disease.
    Wang L; Esteban G; Ojima M; Bautista-Aguilera OM; Inokuchi T; Moraleda I; Iriepa I; Samadi A; Youdim MB; Romero A; Soriano E; Herrero R; Fernández Fernández AP; Ricardo-Martínez-Murillo ; Marco-Contelles J; Unzeta M
    Eur J Med Chem; 2014 Jun; 80():543-61. PubMed ID: 24813882
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multipotent cholinesterase/monoamine oxidase inhibitors for the treatment of Alzheimer's disease: design, synthesis, biochemical evaluation, ADMET, molecular modeling, and QSAR analysis of novel donepezil-pyridyl hybrids.
    Bautista-Aguilera OM; Esteban G; Chioua M; Nikolic K; Agbaba D; Moraleda I; Iriepa I; Soriano E; Samadi A; Unzeta M; Marco-Contelles J
    Drug Des Devel Ther; 2014; 8():1893-910. PubMed ID: 25378907
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Key Targets for Multi-Target Ligands Designed to Combat Neurodegeneration.
    Ramsay RR; Majekova M; Medina M; Valoti M
    Front Neurosci; 2016; 10():375. PubMed ID: 27597816
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 6-Methyluracil derivatives as acetylcholinesterase inhibitors for treatment of Alzheimer's disease.
    Zueva IV; Semenov VE; Mukhamedyarov MA; Lushchekina SV; Kharlamova AD; Petukhova EO; Mikhailov AS; Podyachev SN; Saifina LF; Petrov KA; Minnekhanova OA; Zobov VV; Nikolsky EE; Masson P; Reznik VS
    Int J Risk Saf Med; 2015; 27 Suppl 1():S69-71. PubMed ID: 26639718
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A comprehensive review of multi-target directed ligands in the treatment of Alzheimer's disease.
    Pathak C; Kabra UD
    Bioorg Chem; 2024 Mar; 144():107152. PubMed ID: 38290187
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Recent Appraisal of Small-Organic Molecules as Anti-Alzheimer's Agents.
    Gupta M; Kumar A; Ojha M; Khan SK; Nain S
    Mini Rev Med Chem; 2023; 23(8):962-976. PubMed ID: 36154572
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sarsasapogenin: A steroidal saponin from Asparagus racemosus as multi target directed ligand in Alzheimer's disease.
    Kashyap P; Muthusamy K; Niranjan M; Trikha S; Kumar S
    Steroids; 2020 Jan; 153():108529. PubMed ID: 31672628
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Design, synthesis, and biological evaluation of novel donepezil-tacrine hybrids as multi-functional agents with low neurotoxicity against Alzheimer's disease.
    Wang N; Jia W; Wang J; Yang Z; Liu Y; Huang D; Mei X; Xiong X; Shi J; Tang Y; Chen G; Di D; Hou Y; Liu Y
    Bioorg Chem; 2024 Feb; 143():107010. PubMed ID: 38056387
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel Coumarin-Pyridine Hybrids as Potent Multi-Target Directed Ligands Aiming at Symptoms of Alzheimer's Disease.
    Babaei E; Küçükkılınç TT; Jalili-Baleh L; Nadri H; Öz E; Forootanfar H; Hosseinzadeh E; Akbari T; Ardestani MS; Firoozpour L; Foroumadi A; Sharifzadeh M; Mirjalili BBF; Khoobi M
    Front Chem; 2022; 10():895483. PubMed ID: 35844650
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Design, synthesis, pharmacological evaluation, QSAR analysis, molecular modeling and ADMET of novel donepezil-indolyl hybrids as multipotent cholinesterase/monoamine oxidase inhibitors for the potential treatment of Alzheimer's disease.
    Bautista-Aguilera OM; Esteban G; Bolea I; Nikolic K; Agbaba D; Moraleda I; Iriepa I; Samadi A; Soriano E; Unzeta M; Marco-Contelles J
    Eur J Med Chem; 2014 Mar; 75():82-95. PubMed ID: 24530494
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Management of oxidative stress and other pathologies in Alzheimer's disease.
    Simunkova M; Alwasel SH; Alhazza IM; Jomova K; Kollar V; Rusko M; Valko M
    Arch Toxicol; 2019 Sep; 93(9):2491-2513. PubMed ID: 31440798
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of the "hidden" multi-target-directed ligands by AChE/BuChE for the treatment of Alzheimer's disease.
    Chen R; Li X; Chen H; Wang K; Xue T; Mi J; Ban Y; Zhu G; Zhou Y; Dong W; Tang L; Sang Z
    Eur J Med Chem; 2023 May; 251():115253. PubMed ID: 36921526
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Unleashing new MTDL AChE and BuChE inhibitors as potential anti-AD therapeutic agents: In vitro, in vivo and in silico studies.
    Zaafar D; Elghazawy NH; Hassan A; Mahmoud MY; Bakr AF; Arafa RK
    Int J Biol Macromol; 2024 May; 268(Pt 1):131740. PubMed ID: 38653428
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antioxidant and Cholinesterase Inhibitory Activities of Ethyl Acetate Extract of
    Rajmohamed MA; Natarajan S; Palanisamy P; Abdulkader AM; Govindaraju A
    Pharmacogn Mag; 2017 Oct; 13(Suppl 3):S437-S445. PubMed ID: 29142396
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cyanobiphenyls: Novel H
    Godyń J; Zaręba P; Łażewska D; Stary D; Reiner-Link D; Frank A; Latacz G; Mogilski S; Kaleta M; Doroz-Płonka A; Lubelska A; Honkisz-Orzechowska E; Olejarz-Maciej A; Handzlik J; Stark H; Kieć-Kononowicz K; Malawska B; Bajda M
    Bioorg Chem; 2021 Sep; 114():105129. PubMed ID: 34217977
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Design Synthesis and
    Remya RS; Ramalakshmi N; Nalini CN; Niraimathi V; Amuthalakshmi S
    Curr Comput Aided Drug Des; 2022; 18(4):271-292. PubMed ID: 35927818
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Donepezil-based hybrids as multifunctional anti-Alzheimer's disease chelating agents: Effect of positional isomerization.
    Costa M; Josselin R; Silva DF; Cardoso SM; May NV; Chaves S; Santos MA
    J Inorg Biochem; 2020 May; 206():111039. PubMed ID: 32171933
    [TBL] [Abstract][Full Text] [Related]  

  • 20. First Synthesis of Racemic
    Guieu B; Lecoutey C; Legay R; Davis A; Sopkova de Oliveira Santos J; Altomare CD; Catto M; Rochais C; Dallemagne P
    Molecules; 2020 Dec; 26(1):. PubMed ID: 33375412
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.